Bristol Myers Squibb announced it is deploying its second NVIDIA DGX SuperPOD, built on NVIDIA Vera Rubin architecture, in what the company describes as the life science industry's most advanced AI factory1. BMS already operates one of the largest AI clusters in life sciences; the new system, internally nicknamed the "SuperDuperPOD" by BMS's Erin Davis, doubles the pharmaceutical company's AI compute capacity.
Bristol Myers Squibb Deploying Second NVIDIA DGX SuperPOD on Vera Rubin
Bristol Myers Squibb announced deployment of its second NVIDIA DGX SuperPOD, built on Vera Rubin architecture, expanding its AI compute in life sciences.
